Chemical Auxiliary

99% Raw Antiestrogen powder ?CAS54965-24-1

?

Synonyms: kessar; noltam; tamofen nolva

?

CAS No:54965-24-1

EINECS: 259-415-2

Assay: 97.0%~103.0%

MF: C32H37NO8

MW: 563.64

?

Appearance: White crystalline powder.

?

?

1. Nolvadex is not an anabolic steroid but is used to manage side effects from steroids.
?

2. Nolvadex is a mixed estrogen agonist/antagonist of the same type as Clomid.
?

3. Tamoxifen Citrate is the raw material of Nolvadex.
?

4. Nolvadex is also a kind of medicine to treat cancer.
?

5. Nolvadex (tamoxifen citrate) is very comparable to Clomid.
?

6. Nolvadex behaves in the same manner in all tissues with Clomid.

?

?

Description:

?

Nolvadex (tamoxifen citrate) is very comparable to Clomid, behaves in the same manner in

?

all tissues, and is a mixed estrogen agonist/antagonist of the same type as Clomid. The two

?

molecules are also very similar in structure.

?

It is not correct that Nolvadex reduces levels of estrogen: rather, it blocks estrogen from

?

estrogen receptors and, in those tissues where it is an antagonist, causes the receptor to do

?

nothing.

?

?

The claim that Nolvadex reduces gains should not be taken too seriously. The fact is that

?

any number of bodybuilders have made excellent gains while using Nolvadex. The belief that

?

it reduces gains seems to stem from the fact that the scientific literature reports a slight

?

reduction in IGF-1 (individuals using anabolic steroids were not studied though) from use of

?

Nolvadex.

?

?

Thus, Dan Duchaine reported that it reduces IGF-1 and therefore reduces gains. However,

?

if this effect exists at all, it must be very minor, due to the excellent gains that many have

?

made, and from the fact that no one has noticed any such thing from Clomid, which has the

?

same activity profile.

?

?

However, I would not be surprised if one were to tell a steroid user that Clomid reduced his

?

gains, he would immediately become afraid that Clomid reduced his gains (please note that

?

no one I have ever heard of has noticed this.) Not having been so misled, however, he

?

would not conclude this from his results. But if an authority publishes that such an effect

?

occurs, whether it does or not it can become self-fulfilling by biasing the user.

?

The fact that Nolvadex will reduce water retention may result in the user agreeing that gains

?

are less, since weight gain is less, thus reinforcing the bias.

?

?

Applications:

?

For the treatment of advanced, recurrent breast cancer and ovarian cancer and other

?

illnesses. Used as an antineoplastic raw materials.

?

?

Cook Recipes:

?
50ml @ 20 mg/ml
1 gram of Tamoxifen Citrate
1 beaker suitable for holding the volume of liquids
19.6 ml of Glycerol
29.4 ml of 190 Proof Grain Alcohol
?

?

50ml @ 20 mg/ml


1 gram of Tamoxifen Citrate


1 beaker suitable for holding the volume of liquids


9.8 ml of PEG 600


39.2 ml of 190 Proof Grain Alcohol

?

?

The COA ?of?Tamoxifen Citrate:

?

- - - -
Test Items ? | Specification | Test Results |
Description ? | White crystalline powder | White crystalline powder |
Identification ? | IR , UV conform | Conform |
Loss on drying ? | ≤0.5ml | 0.21ml |
Residue on ignition ? | Not more than 0.2% | 0.06ml |
Iron ? | Not more than 0.005% | 0.0018% |
Heavy metals ? | Not more than 0.001% | 0.0006% |
Related substances ? | Total: Not more than 1.0%
Individual: Not more than 0.5% | 0.32%
0.14% |
E-isomer ? | Not more than 0.3% | 0.19% |
Organic volatile impurities ? | Conforms | Conforms |
Assay ? | 99.0~101.0% | 99.51% |
Conclusion ? | Conform with USP30 |
- - - -

?

?



?

?

?